What is Wegovy?

Wegovy is a brand of Semaglutide. FDA has approved it for 4 uses. People take it once weekly, on the same day each week, at any time of day. The first labeled dose is 0.25 mg. The highest is 7.2 mg.

Source: Current FDA label, checked 2026-08-12

What matters first

Medicine: Semaglutide
How often: Once weekly, on the same day each week, at any time of day
Starting dose: 0.25 mg
Highest labeled dose: 7.2 mg

Choose what you need

Go straight to the answer

DosageWegovy dosage scheduleSee every labeled step from 0.25 mg to 7.2 mg.SafetyWegovy side effectsSee common trial results, serious warnings and later FDA reports.ResultsWegovy weight-loss resultsSee the weeks and study groups behind the reported averages.PriceWhat Wegovy costsCompare the list price, published cash offers and key limits.StorageHow to store WegovyCheck the label rules for temperature, travel and time out of the fridge.Medicine guideRead about SemaglutideSee the medicine behind Wegovy and any other brands that use it.

Approved uses

What is Wegovy approved to treat?

Adults with obesity, or with overweight plus at least one related health condition.

Labeled maintenance: 1.7 mg or 2.4 mg once weekly, 2.4 mg recommended

People age 12 and older with obesity.

Labeled maintenance: 2.4 mg recommended, or 1.7 mg once weekly

Adults with heart disease and obesity or overweight, to lower the risk of heart attack, stroke and heart-related death.

Labeled maintenance: 2.4 mg recommended, or 1.7 mg once weekly

Adults with MASH and moderate to advanced liver scarring, but without cirrhosis.

Labeled maintenance: 2.4 mg once weekly, reducible to 1.7 mg if not tolerated

Not an approved use: The Wegovy label does not cover type 2 diabetes. It never sets a dose for blood sugar control.

The product itself

How Wegovy comes

Single-dose pen

0.25, 0.5, 1, 1.7, 2.4 and 7.2 mg (7.2 mg as Wegovy HD)

1 dose

Single-dose syringe

0.25, 0.5, 1, 1.7 and 2.4 mg

1 dose

Single-patient-use pen (Wegovy FlexTouch)

9.6 mg/3 mL, delivering 2.4 mg per dose

4 doses

Novo Nordisk makes Wegovy under NDA 215256. The label says it is given as a shot under the skin.

Same medicine, different label

How is Wegovy different from Ozempic?

Two brand names use this drug. Wegovy is the one for weight-related care. Ozempic is the one for type 2 diabetes. Their dose plans are not the same.

Read the Ozempic overview

8primary sources, each with the day we read it — open the documents used on this page

Wegovy (semaglutide) injection and tablets — FDA-approved Prescribing Information (DailyMed)retrieved 2026-08-12FDA label
Wegovy (semaglutide) Prescribing Information, revised 06/2026 — Drugs@FDA NDA 215256/S-025retrieved 2026-08-12FDA label
FDA approval letter, NDA 215256 — Wegovy (semaglutide) injection, chronic weight management in adultsretrieved 2026-08-12FDA label
FDA supplement approval letter, NDA 215256/S-005 — Wegovy in pediatric patients aged 12 years and olderretrieved 2026-08-12FDA label
FDA supplement approval letter, NDA 215256/S-011 — Wegovy cardiovascular risk reduction indication (SELECT)retrieved 2026-08-12FDA label
FDA accelerated approval letter, NDA 215256/S-024 — Wegovy for noncirrhotic MASH with stage F2 to F3 fibrosisretrieved 2026-08-12FDA label
FDA supplement approval letter, NDA 215256/S-029 — Wegovy injection 7.2 mg once-weekly doseretrieved 2026-08-12FDA label
FDA approval letter, NDA 218316 — Wegovy (semaglutide) tablets, oral dosage formretrieved 2026-08-12FDA label

Medically reviewed by Jennifer Montecillo, MD · non-practicing medical reviewer